Covered recipient · General Payments record
KENNETH J KAPLAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$28,129.47
- Reported across 1,523 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $4,024.21 | 178 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $1,114.17 | 44 |
| ViiV Healthcare Company | $1,092.78 | 46 |
| Novo Nordisk AS | $301.07 | 16 |
| Lilly USA, LLC | $277.84 | 21 |
| Acerta Pharma LLC | $220.56 | 3 |
| EMD Serono, Inc. | $178.59 | 7 |
| Theratechnologies Inc. | $146.28 | 6 |
| Merck Sharp & Dohme Corporation | $85.92 | 4 |
| Amgen Inc. | $80.20 | 4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $58.93 | 4 |
| Verity Pharmaceuticals Inc. | $52.03 | 2 |
| DEXCOM, INC. | $51.74 | 3 |
| Lundbeck LLC | $49.35 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $39.97 | 2 |
| Sumitomo Pharma America, Inc. | $33.47 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $30.47 | 1 |
| ABBVIE INC. | $28.78 | 2 |
| Janssen Pharmaceuticals, Inc | $26.95 | 1 |
| Exact Sciences Corporation | $26.17 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.58 | 1 |
| Axsome Therapeutics, Inc. | $21.17 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.09 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.12 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.61 | 1 |
| Antares Pharma, Inc. | $16.58 | 1 |
| TOLMAR, INC. | $14.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (178)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.